Caution, page-25

I would conceed that CNE probably had Cath and co on speed dial and new more than what was said.

I didn't expect frequent updates. Wouldn't they need to get conclusive data before reporting it as to not mislead the share holder?

Imagine if scientists gave progressive data on a drug trial for a pharma stock? Early signs may suggest it being more effective than placebo, but then just before the end of the trial, the participants die? The share holders would see a climb and crash, and want the MD's head.

It hasn't been perfect with keeping the SH informed, but don't you think they can get the job done? Find the oil, the can do, prove the oil... If it is, I'm sure they can... Produce... Early days I suppose, might not be an option.